Terms: = Colorectal cancer AND IGH AND Treatment
3 results:
1. Heterogeneous nuclear ribonucleoprotein L facilitates recruitment of 53BP1 and BRCA1 at the DNA break sites induced by oxaliplatin in colorectal cancer.
Hu W; Lei L; Xie X; Huang L; Cui Q; Dang T; Liu GL; Li Y; Sun X; Zhou Z
Cell Death Dis; 2019 Jul; 10(8):550. PubMed ID: 31320608
[TBL] [Abstract] [Full Text] [Related]
2. Characterization of the B Cell Receptor Repertoire in the Intestinal Mucosa and of Tumor-Infiltrating Lymphocytes in colorectal Adenoma and Carcinoma.
Zhang W; Feng Q; Wang C; Zeng X; Du Y; Lin L; Wu J; Fu L; Yang K; Xu X; Xu H; Zhao Y; Li X; Schoenauer UH; Stadlmayr A; Saksena NK; Tilg H; Datz C; Liu X
J Immunol; 2017 May; 198(9):3719-3728. PubMed ID: 28348270
[TBL] [Abstract] [Full Text] [Related]
3. [A case of MALT lymphoma of the colon, stomach, and small intestine].
Sahara K; Tabata T; Arakawa T; Fujiwara T; Egashira H; Fujiwara J; Momma K; Hishima T; Koizumi K; Kamisawa T
Nihon Shokakibyo Gakkai Zasshi; 2015 Feb; 112(2):270-7. PubMed ID: 25748153
[TBL] [Abstract] [Full Text] [Related]
